These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 23542129)
1. Dual roles for lysine 490 of promyelocytic leukemia protein in the transactivation of glucocorticoid receptor-interacting protein 1. Liu ST; Lu GY; Hsu YJ; Chang LC; Ho CL; Huang SM Biochim Biophys Acta; 2013 Aug; 1833(8):1799-810. PubMed ID: 23542129 [TBL] [Abstract][Full Text] [Related]
2. The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome. Baumann CT; Ma H; Wolford R; Reyes JC; Maruvada P; Lim C; Yen PM; Stallcup MR; Hager GL Mol Endocrinol; 2001 Apr; 15(4):485-500. PubMed ID: 11266502 [TBL] [Abstract][Full Text] [Related]
3. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Doucas V; Tini M; Egan DA; Evans RM Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2627-32. PubMed ID: 10077561 [TBL] [Abstract][Full Text] [Related]
4. Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations. Ho CL; Huang YC; Tai CK; Liu ST; Wang JK; Wang WM; Huang SM Int J Biochem Cell Biol; 2010 Jun; 42(6):902-10. PubMed ID: 20097304 [TBL] [Abstract][Full Text] [Related]
5. Role of nuclear bodies in apoptosis signalling. Krieghoff-Henning E; Hofmann TG Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765 [TBL] [Abstract][Full Text] [Related]
7. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells. Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184 [TBL] [Abstract][Full Text] [Related]
8. Sumoylation of Daxx regulates IFN-induced growth suppression of B lymphocytes and the hormone receptor-mediated transactivation. Muromoto R; Ishida M; Sugiyama K; Sekine Y; Oritani K; Shimoda K; Matsuda T J Immunol; 2006 Jul; 177(2):1160-70. PubMed ID: 16818774 [TBL] [Abstract][Full Text] [Related]
9. Selective activation of NFAT by promyelocytic leukemia protein. Lo YH; Wu CC; Shih HM; Lai MZ Oncogene; 2008 Jun; 27(27):3821-30. PubMed ID: 18246125 [TBL] [Abstract][Full Text] [Related]
10. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation. Geng Y; Monajembashi S; Shao A; Cui D; He W; Chen Z; Hemmerich P; Tang J J Biol Chem; 2012 Aug; 287(36):30729-42. PubMed ID: 22773875 [TBL] [Abstract][Full Text] [Related]
11. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation. Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547 [TBL] [Abstract][Full Text] [Related]
12. Analysis of two CBP (cAMP-response-element-binding protein-binding protein) interacting sites in GRIP1 (glucocorticoid-receptor-interacting protein), and their importance for the function of GRIP1. Huang SM; Cheng YS Biochem J; 2004 Aug; 382(Pt 1):111-9. PubMed ID: 15137909 [TBL] [Abstract][Full Text] [Related]
13. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification. Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951 [TBL] [Abstract][Full Text] [Related]
14. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Hofmann TG; Möller A; Sirma H; Zentgraf H; Taya Y; Dröge W; Will H; Schmitz ML Nat Cell Biol; 2002 Jan; 4(1):1-10. PubMed ID: 11740489 [TBL] [Abstract][Full Text] [Related]
15. Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential. Lin DY; Lai MZ; Ann DK; Shih HM J Biol Chem; 2003 May; 278(18):15958-65. PubMed ID: 12595526 [TBL] [Abstract][Full Text] [Related]
16. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266 [TBL] [Abstract][Full Text] [Related]
17. Modulation of glucocorticoid receptor-interacting protein 1 (GRIP1) transactivation and co-activation activities through its C-terminal repression and self-association domains. Liu PY; Hsieh TY; Chou WY; Huang SM FEBS J; 2006 May; 273(10):2172-83. PubMed ID: 16649994 [TBL] [Abstract][Full Text] [Related]
18. The calcium-responsive transactivator recruits CREB binding protein to nuclear bodies. Pradhan A; Liu Y Neurosci Lett; 2004 Nov; 370(2-3):191-5. PubMed ID: 15488321 [TBL] [Abstract][Full Text] [Related]
19. [Structure and functions of isoforms of polyfunctional tumoral suppressor PML]. Zinov'eva MV; Vaĭshlia NA; Vinogradova TV; Kopantsev EP; Sverdlov ED Mol Gen Mikrobiol Virusol; 2009; (2):15-21. PubMed ID: 19517805 [TBL] [Abstract][Full Text] [Related]
20. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms. Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]